B.R.I.D.G.E. TO DATA®
"Kidz with Leukemia: A Space Adventure"
"Conquering Cancer Network"
The Degge Group, Ltd. provides consulting services to the biopharmaceutical and medical products sector specializing in clinical drug safety, pharmacovigilance, medical product epidemiology, and risk management.
Degge's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease studies, risk evaluation and mitigation strategies (REMS), benefit-risk assessments, and pharmacoeconomic and outcomes research.
Degge will help you identify and analyze key data to meet your needs.
Degge's President, Dr. Judith K. Jones, delivered one of 3 keynote speeches: "Pharmacoepidemiology - The Next Thirty Years: From where have we come, and where are we going in the next 30 years." at this year's 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) in Taipei, Taiwan (October 24 - 27, 2014).
"Comorbidity Burden and Healthcare Resource Use in Patients With Idiopathic Pulmonary Fibrosis (IPF) in the United States (US) Military Health System" poster was presented at the CHEST 2014 Annual Meeting held October 25-30, 2014 in Austin, Texas. Co-authors included Earl Goehring Jr, Bao Nguyen, and Judith K Jones. [PDF]
"Discordance rate between two tests used to diagnose patients with HER2-overexpressing breast cancer" poster was presented at the Academy of Managed Care Pharmacy's Annual Meeting held April 1 – 4, 2014 in Tampa, Florida. Coauthors included Earl Goehring Jr, Anokhi Kapasi, and Judith K Jones. The poster was a "Gold Medal Award" winner.
Please click here to review Medicare Part D Notice.
The Degge Group, Ltd.
Consulting in clinical drug safety, pharmacovigilance, and medical product epidemiology since 1988!
9302 Lee Highway, Suite 700
Fairfax, Virginia 22031 USA
Fax: 1 571-490-8408